Clinical Trial Search

Primary: Percentage Change in Area Under The Curve (AUC) for Blood Glucose 0-2 Hours — 301.09; 258.66; 248.63; 274.13 mmol x min/L — p=0.1146

Primary: Diabetes Treatment Satisfaction Questionnaire: Status (DTSQs) Score — 28.2; 31.5; 32.2; 34.2 units on a scale

Primary: Change in HbA1c From Baseline to End — -0.54 HbA1c in percent — p=<0.02

Primary: Change in Glycated Haemoglobin (HbA1c) — -1.16; -1.18 Percentage (%) of HbA1c — p=<0.0001

Primary: Steady-state Plasma Glucose (SSPG) — 130; 139 mg/dL — p=0.01

Primary: Nocturnal Glycemic Control — 3.2; 5.3 Hours — p=0.12

Primary: The Area Under the Curve (AUC) of Plasma Glucose (PG) Concentrations During the 5-hour Postprandial Period (AUC-PG0-5 h). — 724.6; 668.8 mg*h/dl

Primary: Side Effects of Salsalate — 3 participants

Primary: Rate of Type 1 Diabetes Per Year Among Individuals in the Primary Stratum When Treated With Oral Inulin Versus Placebo — 0.088; 0.102 Proportion with diabetes/year

Primary: Change in Glycated Haemoglobin (HbA1c) — -0.93; -0.71 Percentage of HbA1c — p=<0.0001

Primary: Change in Glycosylated Haemoglobin (HbA1c) at Week 26 — -0.47; -0.51 Percentage of HbA1c — p=0.0065

Primary: Change in Glycated Haemoglobin (HbA1c) — -1.55; -1.35 Percentage of HbA1c — p=<0.0001

Primary: Percentage of Blood Glucose Values Within 80-140 mg/dL — 54.8; 21.2 percentage of blood glucose values

Primary: Verbal Memory Composite — -.31247583; .33390008; -.05181561 Change in Z score memory composite

Primary: Time in Low Interstitial Glucose (Defined as Below 54 mg/dL [3 mmol/L]) From Initiation of Treatment (Day 1) to End of Treatment (Day 7) (Percentage) — 0.98; 0.89; 0.69…